Home › Funds › Siren, L.L.C. › MNPR

Siren, L.L.C. position in MNPR

Monopar Therapeutics Inc. · Health Care

Siren, L.L.C. reported holding 270,118 shares of MNPR (Monopar Therapeutics Inc.) in its Q3 2026 13F filing — a position valued at US$21.5M, representing 0.51% of its reported portfolio and ranking #48 among its reported holdings. Siren, L.L.C. has disclosed MNPR holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)270.12K sh
Reported value held$21.52M
Portfolio Weight0.51%
First reportedQ4 2025
Last changeHold
Updated2026-11-12

Last updated: 2026-11-12 · Source: SEC EDGAR Form 13F-HR

How Siren, L.L.C.'s MNPR position evolved

Siren, L.L.C. first disclosed a stake in MNPR in Q4 2025 at 212,298 shares (US$13.9M). The position peaked in Q2 2026 at 270,118 shares, worth US$25.0M. Across 4 filings, Siren, L.L.C. increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 270,118 shares valued at US$21.5M. Notable position changes include a 27% increase in Q1 2026 (shares rose 69% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 212.30K $13.86M New
Q1 2026 270.12K $14.80M Add
Q2 2026 270.12K $25.01M Hold
Q3 2026 270.12K $21.52M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About MNPR and 13F data

MNPR (Monopar Therapeutics Inc.) is a Health Care company. 80 other funds we track also report a position in MNPR — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$61.8M), DEERFIELD MANAGEMENT COMPANY, L.P. (US$30.0M), Saturn V Capital Management LP (US$28.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MNPR

All MNPR fund holders →

FAQ

How long has Siren, L.L.C. held MNPR?

Siren, L.L.C. has disclosed MNPR holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is Siren, L.L.C.'s current position in MNPR?

As of Q3 2026, Siren, L.L.C. holds 270.12K shares of MNPR (Monopar Therapeutics Inc.), valued at $21.52M, representing 0.51% of its reported portfolio and ranking #48.

Has Siren, L.L.C. been buying or selling MNPR?

In the latest 13F filing (Q3 2026), Siren, L.L.C. held unchanged its position in MNPR. The position peaked in Q2 2026 at 270.12K shares.

Which other funds hold MNPR?

Other major institutional holders of MNPR include RA CAPITAL MANAGEMENT, L.P., DEERFIELD MANAGEMENT COMPANY, L.P., Saturn V Capital Management LP, among 80 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.